Technology News and Research

RSS

Widowed population experiences higher mortality rate, says study

Married people in the United States are living longer these days, but the widowed are experiencing a higher mortality rate, according to new research by a Michigan State University sociologist.

3 Dec 2009

Intracranial endovascular procedures will grow at over 5% through 2014 in the US, says MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, intracranial endovascular procedures to treat aneurysms will grow at over 5% through 2014 in the US. MRG's new US Markets for Transcatheter Embolization and Occlusion Devices 2010 report finds that technological advancements in embolization coils as well as imaging and coiling-assist technology will continue to drive growth in aneurysm coiling procedures.

3 Dec 2009

U.S. H1N1 cases decreasing, CDC says; HHS to review approach to health-threat preparedness

The number of H1N1 (swine flu) cases in the U.S. appears to be decreasing, the CDC said Tuesday, CQ HealthBeat reports. "Flu was widespread in 32 states by the end of the week of Nov. 21, a decrease from 43 states in the prior week and 46 states earlier this fall, according to the CDC," the news service writes. "

3 Dec 2009

PPD introduces new centralized computing platform for analysis and reporting of clinical trial data

PPD, Inc. today announced it has launched a new global information technology infrastructure for analysis and reporting of clinical trial data. The biostatistics technology infrastructure (BTI) is a centralized computing platform that enhances the company’s ability to deliver secure, quality reporting and data analysis to meet client timelines.

2 Dec 2009

Novel approach to detect flaws in defense against breast cancer earns Era of Hope Scholar Award

A novel approach to detecting and targeting flaws in first line of defense against cancer has earned an Era of Hope Scholar Award from the U.S. Department of Defense for a scientist at The University of Texas M. D. Anderson Cancer Center.

2 Dec 2009

Aspen Brook Consulting announces 2010 Bioprocess Management Summit

Aspen Brook Consulting, Inc., announces the 2010 Bioprocess Management Summit. This event, occurring February 24th-26th, 2010 at The Canyons Hotel and Conference Center in Park City UT, has been designed as a forum where members of the bioprocess community gather annually to share their knowledge and experience in an effort to address challenges facing the biopharmaceutical industry.

2 Dec 2009

Champions Biotechnology and Ramot establish licensing agreement

Champions Biotechnology, Inc., a U.S. Oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has established an exclusive licensing agreement with Ramot at Tel Aviv University Ltd., Tel Aviv University's wholly owned technology transfer company.

2 Dec 2009

MIT scientists develop computer models to predict realistic drug delivery patterns from stents

MIT scientists including Elazer R. Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Science and Technology (HST), and HST postdoctoral associate Vijaya B. Kolachalama, developed computer models to predict physiologically realistic drug delivery patterns from stents in branched arterial vessels.

2 Dec 2009

New CareTracker Clinical Intelligence technology to be introduced in 187 health centers

Resource Systems, developer of long-term care electronic documentation system CareTracker, and Extendicare Health Services, Inc., a leading provider of senior care with over 260 health centers across U.S. and Canada, announce Extendicare's commitment to introduce the new CareTracker Clinical Intelligence technology to 187 health centers. The Clinical Intelligence tool assists health centers in predicting and notifying caregivers of potential resident care issues before they become a problem.

2 Dec 2009

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the filing of a new United States patent application entitled “POU5-F1 Expression in Human Mesenchymal Stem Cells” and the development of new technology related to generation of human induced pluripotent stem cells (iPS).

2 Dec 2009

University of Pittsburgh's McGowan Institute for Regenerative Medicine awarded IBM SUR grant

The University of Pittsburgh's McGowan Institute for Regenerative Medicine, which connects scientists who work on tissue engineering, cell therapies, artificial organs and biodevices, has been awarded a Shared University Research (SUR) Award from IBM ( IBM). The IBM SUR Award will provide IBM computer hardware, software and services to Pitt for its cutting-edge "in silico" biological research, which uses computer simulations to explore biological pathways and test therapeutic interventions.

2 Dec 2009

Officials to review U.S. health-threat response systems

The Washington Post: "Citing the balky swine flu vaccination campaign and other shortcomings in the nation's medical defenses, a top Obama administration official has announced a major review of the government's efforts to develop new protections against pandemics, bioterrorism and other health threats."

2 Dec 2009

Sorin Group includes the first patient in its Clepsydra clinical trial

Sorin Group announced today the first inclusion of a patient in the Clepsydra clinical trial. The study will investigate the sensitivity to changes in heart failure status of PhD™, a unique diagnostic feature using the dual sensor technology of minute ventilation and accelerometer to monitor patient’s breathing and activity levels every day.

2 Dec 2009

Ellipse Technologies presents clinical results of its MAGEC System study

Ellipse Technologies, Inc. announced today that a scientific presentation of the pre-human clinical results of the MAGEC System were presented by Dr. Gregory Mundis at the 3rd International Congress on Early Onset Scoliosis and Growing Spine held in Istanbul, Turkey, November 20 and 21st.

2 Dec 2009

Butler Health System implements PatientKeeper’s Platform and Physician Portal

PatientKeeper®, Inc., the leading provider of Physician Information Technology, announced today that Butler Health System of Butler, Pennsylvania selected PatientKeeper to help its organization meet the meaningful use criteria requirements established by the American Recovery and Reinvestment Act (ARRA). The implementation of PatientKeeper’s Platform and Physician Portal, which is scheduled to roll-out in the first quarter of 2010, will extend physician accessibility and connectivity to over 200 physicians and significantly impact patient quality and care.

2 Dec 2009

URMC implements Allocade's artificial intelligence based solution to manage patient flow and logistics

The University of Rochester Medical Center (URMC) and Allocade, Inc., today announced the first installation and implementation of the On-Cue™ system in New York. URMC is utilizing the On-Cue software solution from Allocade to automate patient flow throughout the hospital and improve operational efficiencies by creating dynamic patient itineraries. The On-Cue system utilizes artificial intelligence, offering healthcare an efficient operating system that helps caregivers to effectively manage patient flow and logistics.

2 Dec 2009

American Scientific Resources commences production of its FDA approved home needle destruction device

American Scientific Resources, Inc., announces that the Disintegrator Plus(TM), the world's only FDA approved home needle destruction device (NDD), is in its first production run for ASR.

2 Dec 2009

FDA approves revised clinical trial protocol for CytRx' arimoclomol

CytRx Corporation, a biopharmaceutical company, is permitted to re-enter the clinic with its orally administered molecular chaperone drug candidate arimoclomol as a therapeutic treatment for amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), following the U.S. Food and Drug Administration’s (FDA) acceptance of a revised clinical trial protocol.

2 Dec 2009

Favorable initial results from Novavax' 2009 H1N1 VLP pandemic influenza vaccine Phase II study

Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.

2 Dec 2009

TARIS Biomedical completes Phase 1 study of its intravesical drug-device convergence system

TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, announced today the successful completion of a Phase 1 clinical study of its intravesical drug-device convergence system designed to provide sustained-release of drug directly to the bladder.

2 Dec 2009

Technology News and Research

Widowed population experiences higher mortality rate, says study

Intracranial endovascular procedures will grow at over 5% through 2014 in the US, says MRG

U.S. H1N1 cases decreasing, CDC says; HHS to review approach to health-threat preparedness

PPD introduces new centralized computing platform for analysis and reporting of clinical trial data

Novel approach to detect flaws in defense against breast cancer earns Era of Hope Scholar Award

Aspen Brook Consulting announces 2010 Bioprocess Management Summit

Champions Biotechnology and Ramot establish licensing agreement

MIT scientists develop computer models to predict realistic drug delivery patterns from stents

New CareTracker Clinical Intelligence technology to be introduced in 187 health centers

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

University of Pittsburgh's McGowan Institute for Regenerative Medicine awarded IBM SUR grant

Officials to review U.S. health-threat response systems

Sorin Group includes the first patient in its Clepsydra clinical trial

Ellipse Technologies presents clinical results of its MAGEC System study

Butler Health System implements PatientKeeper’s Platform and Physician Portal

URMC implements Allocade's artificial intelligence based solution to manage patient flow and logistics

American Scientific Resources commences production of its FDA approved home needle destruction device

FDA approves revised clinical trial protocol for CytRx' arimoclomol

Favorable initial results from Novavax' 2009 H1N1 VLP pandemic influenza vaccine Phase II study

TARIS Biomedical completes Phase 1 study of its intravesical drug-device convergence system

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News